Organisation paid for research Program year 2025 Source: CMS Open Payments

Bioluminux Clinical Research Illinois

Neither a doctor nor a teaching hospital

Research payments

$165,118

4 payments

Through program year 2025, Bioluminux Clinical Research Illinois is reported as receiving $165,118 in research payments, across 4 payments.

By program year

1 row
Year Kind Amount Payments
2025 Research $165,118 4

Breakdown

Who paid Research payments · program year 2025
  1. Vertex Pharmaceuticals Incorporated $128,150 1 payment
  2. Pfizer Inc. $36,968 3 payments
Studies the money was for Research payments · program year 2025
  1. A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER) $128,150 1 payment
  2. A Phase 2B Multicenter Randomized Doubleblind Placebocontrolled Study to Evaluate the Efficacy and Safety of Onceweekly Met097 in Adults With Obesity Or Overweight and Type 2 Diabetes Mellitus Vesper2 $36,968 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record